Medicine and Health
The efficacy and adverse events of conventional and second-generation androgen receptor inhibitors for castration-resistant prostate cancer: A network meta-analysis
X. Zhang, G. Zhang, et al.
Discover the findings of an exciting network meta-analysis that uncovers the superior efficacy of second-generation androgen receptor inhibitors over conventional treatments for castration-resistant prostate cancer. This research was conducted by Xianlu Zhang, Gejun Zhang, Jianfeng Wang, Jianbin Bi, Xiaolan Deng, Yanlong Wang, and Yinu Wang.
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.
